JDCR-D-21-00326R3, Pyoderma gangrenosum in a patient on ixekizumab
收藏数据链接：
官方服务：
资源简介：
Supplemental data for case report
应用场景：
创建时间：
2021-01-01
相关数据集
Safety outcomes in the patients who received an injection of the investigational product.
Safety outcomes in the patients who received an injection of the investigational product.
Figshare2019-12-10 更新50
Additional file 2 of A retrospective analysis of cardiovascular adverse events associated with immune checkpoint inhibitors
Additional file 2. Tumor Histology acronyms.
Figshare2021-05-28 更新30
Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: A general practice-based, observational study
Data on hyperkalemia frequency among chronic kidney disease (CKD) patients receiving renin-angiotensin aldosterone system inhibitors (RAASis) and its impact on subsequent RAASi treatment are limited.
Figshare2019-03-07 更新10
Rapid Ventricular Tachycardias Associated with Cilostazol Use
A 92-year-old woman with normal systolic function had recently begun using the newly approved phosphodiesterase III inhibitor cilostazol when she was admitted with lower-extremity pain. Cilostazol is
PubMed Central30
Overall summary of adverse events (treated set).
aPatients were randomised 2:2:1 to the tiotropium Respimat 5 μg, tiotropium Respimat 2.5 μg and placebo Respimat groups, respectively. bAs determined by the investigator. cElevation of aspartate amino
NIAID Data Ecosystem20
